Title : Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3).

Pub. Date : 2019

PMID : 31040679






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Previously reported clinical trials have demonstrated the efficacy of the investigational agent buprenorphine/samidorphan (BUP/SAM) combination, an opioid-system modulator, for the adjunctive treatment of major depressive disorder. Buprenorphine COMM domain containing 3 Homo sapiens